KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) EBIT Margin: 2009-2025

Historic EBIT Margin for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to 13.71%.

  • Quest Diagnostics' EBIT Margin rose 44.00% to 13.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.11%, marking a year-over-year increase of 99.00%. This contributed to the annual value of 13.63% for FY2024, which is 1.00% down from last year.
  • Latest data reveals that Quest Diagnostics reported EBIT Margin of 13.71% as of Q3 2025, which was down 13.59% from 15.86% recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' EBIT Margin ranged from a high of 24.26% in Q1 2021 and a low of 5.79% during Q4 2022.
  • In the last 3 years, Quest Diagnostics' EBIT Margin had a median value of 13.71% in 2025 and averaged 13.79%.
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 1,466bps in 2021, then crashed by 1,375bps in 2022.
  • Over the past 5 years, Quest Diagnostics' EBIT Margin (Quarterly) stood at 19.53% in 2021, then slumped by 1,375bps to 5.79% in 2022, then soared by 588bps to 11.67% in 2023, then surged by 210bps to 13.77% in 2024, then surged by 44bps to 13.71% in 2025.
  • Its last three reported values are 13.71% in Q3 2025, 15.86% for Q2 2025, and 13.05% during Q1 2025.